Filing Details

Accession Number:
0001289340-12-000093
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-12-04 16:26:48
Reporting Period:
2012-11-30
Filing Date:
2012-12-04
Accepted Time:
2012-12-04 16:26:48
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1289340 Stereotaxis Inc. STXS Electromedical & Electrotherapeutic Apparatus (3845) 943120386
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1267959 A Fred Middleton 400 South El Camino Real
Suite 1200
San Mateo CA 94402-1708
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-11-30 24,360 $1.53 76,072 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 782,272 Indirect Sanderling Venture Partners VI Co-Investment Fund, L.P.
Common Stock 28,117 Indirect Sanderling Ventures Management VI
Common Stock 3,060 Indirect Sanderling VI Beteiligungs GmbH & Co. KG
Common Stock 3,647 Indirect Sanderling VI Limited Partnership
Common Stock 1,500 Indirect Sanderling Mgmt. LLC 401K Pension Profit Sharing Plan
Common Stock 53,275 Indirect Sanderling IV Biomedical Co-Investment Fund, L.P.
Common Stock 11,097 Indirect Sanderling V Beteiligungs GmbH & Co. KG
Common Stock 39,716 Indirect Sanderling V Biomedical Co-Investment Fund, L.P.
Common Stock 11,956 Indirect Sanderling V Limited Partnership
Common Stock 67,790 Indirect Sanderling Venture Partners V Co-Investment Fund, L.P.
Common Stock 22,451 Indirect Sanderling Venture Partners IV Co-Investment Fund
Common Stock 82 Indirect Sanderling Ventures Management V
Common Stock 79 Indirect Middleton McNeil Retirement Trust
Footnotes
  1. Purchase of 24,360 shares of Stereotaxis, Inc. common stock from the limited partners of Sanderling Venture Partners II, LP in connection with the liquidation of the partnership. In previous reports, the reporting person reported indirect beneficial ownership in 78,135 shares of Stereotaxis, Inc. common stock held by Sanderling Venture Partners II, LP.
  2. Includes pro-rata liquidating disribution of 6,148 shares from Sanderling Venture Partners, II LP. In previous reports, the reporting person reported indirect beneficial ownership in 78,135 shares of Stereotaxis, Inc. common stock held by Sanderling Venture Partners II, LP.